Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tetracycline Drain for Alveolar Osteitis
NCT03494972Completed
- Sponsor
- University of Oslo
- Start
- Jan 2016
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of Oxytetracycline in alveolar osteitis (AO) (2 arms), sponsored by University of Oslo. Primary endpoint: Alveolar osteitis at 1 week. Started Jan 2016; status: completed.
02
Drugs
Oxytetracycline
03
Conditions
alveolar osteitis (AO)
Beyond the preview
Go deeper on NCT03494972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03494972.